Delivery Order SPE2DE24D0013-SPE2D626F933D
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $5,775.00 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. The delivery order, designated XPRS-COV2-10, is expected to be completed by November 20, 2025, and carries no set-aside designation. This award represents a task order issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $9,520 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 6, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 13, 2025, and carries no set-aside designation. The contract nomenclature indicates the order pertains to diagnostic testing capabilities for COVID-19, influenza, and respiratory...
- On November 26, 2025, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,120 to Cepheid Inc., a molecular diagnostic systems manufacturer headquartered in Sunnyvale, California. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, calls for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus. The order is scheduled for completion by December 4, 2025, and carries no set-aside designation....
- This delivery order, valued at $1,235.85, was awarded to Cepheid Inc. on November 25, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic supplies supporting federal healthcare operations. The order, designated as XPRSARS-COV2-10, is structured as a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by December 10, 2025. Performance will be executed at Cepheid's headquarters facility in Sunnyvale, California. This award...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,815 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 7, 2025, with ultimate completion targeted for August 21, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with one of Cepheid's existing Indefinite Delivery Vehicle contracts with...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $5,440 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on May 6, 2025, with an ultimate completion date of May 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus detection. The award carries no set-aside designation and represents a continuation...
- This delivery order, valued at $7,700.00, was awarded on November 4, 2025, by the Defense Logistics Agency Medical Supply Chain to Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems. The award represents a firm fixed-price delivery order with no set-aside designation for diagnostic testing supplies, likely including XPRS-COV2-10 cartridges or related reagents for the company's GeneXpert diagnostic platform. The contract is scheduled for ultimate...
- The Defense Department's Medical Supply Chain agency awarded a $1,540 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on September 3, 2025, with an ultimate completion date of September 10, 2025. The contract, designated XPRSARS-COV2-10, carries no set-aside designation and represents a delivery order likely issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a $12,086.88 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The delivery order, issued on August 6, 2025, with completion targeted for August 13, 2025, is designated XPCOV2/FLU/RSV-10 and carries no set-aside designation. This award represents a delivery order issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, likely the...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $3,850 delivery order (Contract No. XPRS-COV2-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on October 15, 2025, with an ultimate completion date of October 22, 2025, carries no set-aside designation. The award leverages Cepheid's established capability in providing molecular diagnostic testing systems and reagents, which the...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F933DDelivery Order
On December 8, 2025, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,694.00 to Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems. This firm fixed-price delivery order, designated XPRSARS-COV2-10, is expected to be completed by December 22, 2025, and represents an order for diagnostic testing supplies under Cepheid's existing indefinite delivery contract with the Department of Veterans Affairs. The award carries no set-aside designation and involves no identified subcontractors. The delivery order is for XPRS-COV2-10 cartridges designed for the GeneXpert diagnostic platform, which detects COVID-19 and other respiratory pathogens. This delivery order is issued under Cepheid's broader indefinite delivery contract vehicle with the Veterans Integrated Service Network (VISN) system, which establishes the framework for ongoing procurement of molecular diagnostic reagents and test kits across the federal healthcare system. Cepheid has established itself as a primary federal supplier of diagnostic solutions, serving multiple healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company's GeneXpert platform provides rapid molecular diagnostic testing capabilities for infectious diseases including COVID-19, influenza, respiratory syncytial virus, and other conditions, making it integral to federal healthcare laboratory operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/7/25 |